Breast Cancer Clinical Trials in Columbia, SC

Breast Cancer Clinical Trials in Columbia, SC

View the best 10 breast cancer medical studies in Columbia, South Carolina. Access promising new therapies by applying to a Columbia-based Breast Cancer clinical trial.

Trials in Columbia, South Carolina

Here are the top 10 medical studies for breast cancer in Columbia, South Carolina

Image of University of South Carolina in Columbia, United States.

Physical activity adoption

Behavioral Intervention

Recruiting1 award6 criteria
This trialwill measure effects of a 3-month physical activity intervention on breast cancer survivors not currently active. A web-based platform and virtual calls with a peer coach will be used to increase activity. Participants will be given a Fitbit to monitor activity.
Image of UCSF in San Francisco, United States.

Palbociclib

CDK4/6 Inhibitor

Recruiting2 awardsPhase 3
This trial is testing whether adding a new drug to standard treatment can improve outcomes for people with hormone receptor-positive, HER2+ metastatic breast cancer.
Image of Research Site in Mobile, United States.

Anastrozole +2 More

Aromatase Inhibitor

Recruiting1 awardPhase 3
This trial is comparing two drug combinations to treat a specific type of advanced breast cancer. One combination includes a new drug called camizestrant, and the other includes anastrozole. Both combinations also use palbociclib. The goal is to see which combination works better at slowing down the cancer.
Image of Research Site in Farmington, United States.

Camizestrant

Selective Estrogen Receptor Degrader (SERD)

Recruiting2 awardsPhase 3
This trial is testing camizestrant, a drug that blocks estrogen, in patients with ER+/HER2- early breast cancer at medium to high risk of recurrence. The goal is to see if it works better than standard hormone treatments by stopping cancer cells from growing.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Fludeoxyglucose F-18

Recruiting1 awardPhase 2
This trial studies how well certain scans work in assessing the response of patients with breast cancer that has spread to the bones. The scans use a special substance to highlight active cancer areas on detailed body images, helping doctors see if the treatment is working. These scans have been used successfully for various stages and evaluations of breast cancer.
Image of Oncology Consultants in Houston, United States.

Paclitaxel +1 More

Anti-tumor antibiotic

Recruiting0 awardsPhase 2 & 3
This trial will compare a chemo-immunotherapy to chemotherapy alone to see if it can better treat metastatic breast cancer.
Image of University of South Alabama - Mitchell Cancer Institute in Mobile, United States.

T-DM1 +1 More

Antibody Drug Conjugate

Recruiting1 awardPhase 3
This trial is being done to see if adding tucatinib to T-DM1 helps patients with HER2 positive breast carcinoma.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Trastuzumab Emtansine

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial tests a combination of two drugs to see if they're better than one drug at preventing breast cancer from coming back in patients with high risk, HER2 positive breast cancer.
Image of Pacific Cancer Care ( Site 0142) in Monterey, United States.

Pembrolizumab +1 More

Immune Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is comparing the efficacy of two different treatments for triple negative breast cancer - olaparib plus pembrolizumab versus chemotherapy plus pembrolizumab. The primary hypotheses are that olaparib plus pembrolizumab will be superior to chemotherapy plus pembrolizumab in terms of progression-free survival and overall survival.
Image of Research Site in Columbus, United States.

Arm B: camizestrant ± abemaciclib

Recruiting2 awardsPhase 3
This trial studies if a new drug can help improve outcomes for breast cancer patients with a high risk of recurrence. Treatment lasts 7 years.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.